US Patent 9079880 Rho kinase inhibitors
Patent 9079880 was granted and assigned to Boehringer Ingelheim on July, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 29, 2011
0
Date of Patent
July 14, 2015
0
Patent Application Number
13171701
0
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9079880 Rho kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.